December 12, 2022
Semler Announces Investment in Monarch Medical Technologies
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific’s mission is to develop, manufacture and market innovative products and services that assist its customers in evaluating and treating chronic diseases.
November 9, 2021
EndoTool Subcutaneous Inpatient Insulin Dosing Solution Simplifies Provider Workflow While Improving Patient Safety
Monarch Medical Technologies, maker of the EndoTool® Glucose Management System, received FDA clearance for its enhanced software for the treatment of inpatient hyperglycemia using subcutaneous insulin.
September 17, 2020
Monarch Medical Technologies Achieves ISO 13485 Certification
Monarch Medical Technologies has earned ISO 13485:2016 certification for its quality management system from the independent certifying body, TÜV SÜD.
July 10, 2019
Mercyhealth Partners With Monarch Medical Technologies to Optimize Inpatient Diabetes Management
Mercyhealth, a multi-regional healthcare system serving northern Illinois and southern Wisconsin, is partnering with Monarch Medical Technologies to improve care for patients with diabetes or stress-induced hyperglycemia.
June 17, 2019
Monarch Medical Technologies and Voluntis to Host Webinar on Use of Technology to Support Inpatient and Outpatient Insulin Management
Monarch and Voluntis are partnering to offer a complimentary webinar, “How Technology Can Support Adoption of Best Practices for Inpatient and Outpatient Insulin Management.”
June 10, 2019
Patrick Burgess, MD: Hypoglycemia and Impact of Late Glucose Checks
An article published by MD Magazine (now HCPLive) explores the findings of a study on the correlation between late blood glucose checks and incidence of hypoglycemia, presented by Dr. Patrick Burgess at the American Diabetes Association Scientific Sessions.
June 7, 2019
Monarch Medical Technologies Announces New Insulin-on-Board Adjustment for Subcutaneous Insulin Dosing
The company has obtained an additional clearance for an optional insulin-on-board (IOB) calculation to mitigate the risk of low glucose values as a result of residual rapid-acting insulin.
June 4, 2019
Monarch Medical Technologies to Participate in American Diabetes Association 79th Scientific Sessions and DiabetesMine D-Data ExChange
Monarch will be participating in the DiabetesMine D-Data ExChange on June 7, 2019 and the American Diabetes Association’s 79th Scientific Sessions on June 7-11, 2019 in San Francisco, CA.
April 29, 2019
Retrospective Analysis Produced by Monarch Medical Technologies Explores Effect of Blood Glucose Goal Range and Two-Hour Blood Glucose Checks on Hypoglycemia Incidence
The two studies analyze a database of nearly one million blood glucose readings from approximately 45,000 patients who were prescribed intravenous insulin dose recommendations using the EndoTool® Glucose Management System.
February 28, 2019
Monarch Medical Technologies Hosts Webinar on Inpatient Diabetes Care Quality Improvement
The complimentary webinar, “Breaking the Barriers of Inpatient Glycemic Management Quality Improvement,” features Dr. Sandy Fogel of Carilion Clinic.
February 12, 2019
Monarch Medical Technologies Introduces New Online Community for Users of the EndoTool Glucose Management System
Available to EndoTool clients, the portal provides the ability to research relevant topics, interact with other users, and pose questions to both the Monarch team and other client organizations.
January 22, 2019
Monarch Medical Technologies Appoints Expert in Pediatric Diabetes, Dr. Mark Vanderwel, to Medical Advisory Board
Joining a board of diabetes experts, Dr. Vanderwel will bring expertise in pediatric endocrinology to support Monarch in the continual advancement of the EndoTool® Glucose Management System.
January 13, 2019
Glucose Management Technologies for the Critically Ill
An article published by Drs. Pedro Salinas and Carlos Mendez in the Journal of Diabetes Science and Technology explores the efficacy of technology solutions for glycemic care in the hospital setting, with a specific focus on the critically ill patient population.
October 23, 2018
Automated Insulin Dosing — Past, Present and Future
An article published by Insulin Nation explores the past, present and future of automated insulin dosing, including various tools and algorithms used within the hospital setting and new developments such as CGM and insulin pumps for the outpatient setting.
October 19, 2018
Convincing Hospitals That Glucose Management Matters
A blog post published by DiabetesMine explores why many hospitals still use an old-fashioned, time-consuming, error-prone approach to glucose management versus a technology-enabled approach like EndoTool, noting a big challenge is convincing hospital administration and providers this should be a priority.